You have 7 free searches left this month | for more free features.

Potassium Binders

Showing 26 - 50 of 755

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Kidney Diseases, Heart Failure With Reduced Ejection Fraction, Hyperkalemia Trial in London (Lokelma Oral Product)

Recruiting
  • Chronic Kidney Diseases
  • +4 more
  • Lokelma Oral Product
  • London, United Kingdom
    St Georges, University of London
Feb 16, 2022

Keloid Trial (Ethosomal gel bearing losartan 5%, triamcinolone acetonide 10 mg/ml)

Not yet recruiting
  • Keloid
  • Ethosomal gel bearing losartan 5%
  • triamcinolone acetonide 10 mg/ml
  • (no location specified)
Jun 5, 2023

Colonoscopy Trial (DWJ1609, DWC202304)

Not yet recruiting
  • Colonoscopy
  • (no location specified)
Sep 24, 2023

Working Memory, Post-covid-19 Trial in Basel (Fampridine SR, Placebo)

Recruiting
  • Working Memory
  • Post-covid-19
  • Fampridine SR
  • Placebo
  • Basel, BS, Switzerland
    University of Basel, Transfaculty Research Platform
Dec 22, 2022

Serum Potassium asPredictor of Clinical Outcomes inOlder Patient

Completed
  • Potassium, Decreased Level
  • Postsurgical Pain, Chronic
  • NO intervention
  • Beijing, Beijing, Beijing, China, China
    Chinese PLA General Hospital
May 22, 2022

Pulp Disease, Dental Trial in Al Minya (potassium nitrate in polycarboxilate cement)

Active, not recruiting
  • Pulp Disease, Dental
  • potassium nitrate in polycarboxilate cement
  • Al Minya, Egypt
    Minia University
Jun 11, 2023

Cardiovascular Health, Cardiovascular Risk Factor Trial in Newark (Potassium chloride supplement, Placebo)

Recruiting
  • Cardiovascular Health
  • Cardiovascular Risk Factor
  • Potassium chloride supplement
  • Placebo
  • Newark, Delaware
    Tower at STAR
May 30, 2023

Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral) Trial in Shanghai (Sodium)

Completed
  • Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
  • Sodium
  • Shanghai, Shanghai, China
    Yiran Jiang
Dec 7, 2022

Kidney Stone Trial in Chicago (Potassium citrate, Crystal light, Potassium citrate + crystal light)

Recruiting
  • Kidney Stone
  • Potassium citrate
  • +2 more
  • Chicago, Illinois
    Northwestern University
Jan 23, 2023

Hyperkalemia Trial in United States (RDX013, Placebo)

Completed
  • Hyperkalemia
  • Coral Gables, Florida
  • +5 more
May 3, 2022

Dentin Sensitivity, Oral Hygiene Trial in Las Vegas (Test Dentifrice, Reference Dentifrice (Aquafresh Cavity Protection))

Not yet recruiting
  • Dentin Sensitivity
  • Oral Hygiene
  • Test Dentifrice
  • Reference Dentifrice (Aquafresh Cavity Protection)
  • Las Vegas, Nevada
    Silverstone Research Group
Nov 21, 2023

Electrolyte Disorders in Prediabetics and in Type 2 Diabetes

Not yet recruiting
  • Type 2 Diabetes Mellitus and Electrolyte Disorders
    • (no location specified)
    Apr 2, 2023

    Myoclonus Epilepsies, Progressive Trial in Philadelphia (AUT00201, Placebo)

    Recruiting
    • Myoclonus Epilepsies, Progressive
    • Philadelphia, Pennsylvania
      University of Pennsylvania, Penn Epilepsy Center
    May 15, 2023

    Hyperkalemia Trial in Worldwide (Patiromer)

    Terminated
    • Hyperkalemia
    • Palo Alto, California
    • +29 more
    Oct 17, 2022

    Vascular Function, Healthy, Diabetes Trial (Soup)

    Not yet recruiting
    • Vascular Function
    • +2 more
    • Soup
    • (no location specified)
    Jul 28, 2023

    Molluscum Contagiosum Trial in Abbottabad (potassium hydroxide)

    Completed
    • Molluscum Contagiosum
    • potassium hydroxide
    • Abbottabad, KPK, Pakistan
      CMH
    Nov 22, 2022

    Hyperkalemia, Hypokalemia Trial in Taipei (AI-enabled ECG-based Screening Tool)

    Recruiting
    • Hyperkalemia
    • Hypokalemia
    • AI-enabled ECG-based Screening Tool
    • Taipei, Taiwan
      National Defense Medical Center
    Nov 2, 2022

    Sodium Zirconium Cyclosilicate, Hyperkalemia, Hyperparathyroidism, Secondary Trial (Sodium zirconium cyclosilicate)

    Completed
    • Sodium Zirconium Cyclosilicate
    • +2 more
    • Sodium zirconium cyclosilicate
    • (no location specified)
    May 16, 2022

    Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Apatinib Mesylate Tablets, Tegafur Gimeracil Oteracil Potassium

    Completed
    • Head and Neck Squamous Cell Carcinoma
    • Apatinib Mesylate Tablets
    • Tegafur Gimeracil Oteracil Potassium Capsules
    • Shanghai, Shanghai, China
      Shanghai ninth people's hospital
    Jul 20, 2022

    Hyperkalaemia, Heart Failure With Reduced Ejection Fraction Trial in Worldwide (Sodium zirconium cyclosilicate, Placebo,

    Recruiting
    • Hyperkalaemia
    • Heart Failure With Reduced Ejection Fraction
    • Sodium zirconium cyclosilicate
    • +2 more
    • Fairhope, Alabama
    • +126 more
    Jan 20, 2023

    MDD Trial in New York, Houston (XEN1101, Placebo)

    Recruiting
    • Major Depressive Disorder
    • New York, New York
    • +1 more
    Nov 8, 2022

    H.Pylori Infection Trial in Beijing (Rifasutenizol capsules, Rabeprazole sodium enteric-coated tablets, Amoxicillin Capsules)

    Not yet recruiting
    • H.Pylori Infection
    • Rifasutenizol capsules
    • +7 more
    • Beijing, China
      Peking University Third Hospital
    May 3, 2023

    Molluscum Contagiosum Treated With5% Solution of Potassium

    Not yet recruiting
    • Molluscum Contagiosum
      • Multiple Locations, France
        Multiple locations
      Dec 24, 2022

      Renal Insufficiency, Chronic, Potassium Depletion, Hypertension Trial in Netherlands (Potassium Chloride, Potassium Citrate,

      Recruiting
      • Renal Insufficiency, Chronic
      • +3 more
      • Potassium Chloride
      • +2 more
      • Amsterdam, Netherlands
      • +3 more
      Jan 15, 2022

      Viscous Fiber on Postprandial Kalemic Response in Hemodialysis

      Enrolling by invitation
      • Hyperkalemia
      • Chronic Kidney Disease Requiring Chronic Dialysis
      • Kalemic Response to Orange Juice
      • Kalemic Response to Orange Juice with Fiber
      • Reno, Nevada
        University of Nevada,Reno
      Oct 6, 2021